Biosino Bio-Technology and Science Incorporation Balance Sheet Health
Financial Health criteria checks 4/6
Biosino Bio-Technology and Science Incorporation has a total shareholder equity of CN¥155.1M and total debt of CN¥136.8M, which brings its debt-to-equity ratio to 88.2%. Its total assets and total liabilities are CN¥435.1M and CN¥280.0M respectively.
Key information
88.23%
Debt to equity ratio
CN¥136.84m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥46.35m |
| Equity | CN¥155.09m |
| Total liabilities | CN¥280.04m |
| Total assets | CN¥435.13m |
Recent financial health updates
Biosino Bio-Technology and Science Incorporation (HKG:8247) Has Debt But No Earnings; Should You Worry?
Oct 06
Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way?
Apr 01Recent updates
Biosino Bio-Technology and Science Incorporation (HKG:8247) Has Debt But No Earnings; Should You Worry?
Oct 06Biosino Bio-Technology and Science Incorporation's (HKG:8247) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Aug 07Here's Why Some Shareholders May Not Be Too Generous With Biosino Bio-Technology and Science Incorporation's (HKG:8247) CEO Compensation This Year
May 23Biosino Bio-Technology and Science Incorporation's (HKG:8247) 28% Dip In Price Shows Sentiment Is Matching Revenues
Apr 23Biosino Bio-Technology and Science Incorporation's (HKG:8247) Business And Shares Still Trailing The Industry
Oct 31Biosino Bio-Technology and Science Incorporation's (HKG:8247) 26% Dip In Price Shows Sentiment Is Matching Revenues
Jun 27Shareholders Will Probably Be Cautious Of Increasing Biosino Bio-Technology and Science Incorporation's (HKG:8247) CEO Compensation At The Moment
Jun 21Biosino Bio-Technology and Science Incorporation (HKG:8247) Held Back By Insufficient Growth Even After Shares Climb 46%
Apr 22Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way?
Apr 01Biosino Bio-Technology and Science Incorporation's (HKG:8247) 31% Dip In Price Shows Sentiment Is Matching Revenues
Feb 08Some Confidence Is Lacking In Biosino Bio-Technology and Science Incorporation (HKG:8247) As Shares Slide 38%
Jul 31Financial Position Analysis
Short Term Liabilities: 8247's short term assets (CN¥245.9M) do not cover its short term liabilities (CN¥272.7M).
Long Term Liabilities: 8247's short term assets (CN¥245.9M) exceed its long term liabilities (CN¥7.4M).
Debt to Equity History and Analysis
Debt Level: 8247's net debt to equity ratio (58.3%) is considered high.
Reducing Debt: 8247's debt to equity ratio has reduced from 103.3% to 88.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 8247 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 8247 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 15.1% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/08 08:10 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biosino Bio-Technology and Science Incorporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| T. J. Hsu | KGI Securities Co. Ltd. |